Katarı́na Rašlová

EU-Wi<i>d</i>e Cross-Section<i>a</i>l Obser<i>v</i>at<i>i</i>o<i>n</i>al Study of Lipid-Modifying Therapy Use in Se<i>c</i>ondary and Pr<i>i</i>mary Care: the DA VINCI study

Kausik K. Ray, Bart Molemans, W. Marieke Schoonen et al. · European Journal of Preventive Cardiology · 2020 · 767 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Comet assay in human biomonitoring studies: Reliability, validation, and applications

Andrew Collins, Mária Dušinská, Michael Franklin et al. · Environmental and Molecular Mutagenesis · 1997 · 655 citations

Pharmacy, Cell Biology, Toxicology +17

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 305 citations · Full text

Public Health, Endocrinology, Genetics +13

Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes

Katarı́na Rašlová, M. Bogoev, Itamar Raz et al. · Diabetes Research and Clinical Practice · 2004 · 198 citations

Medicine, Endocrinology, Diabetology +12